C71T
CANCELLED SECTION 71
24/04/2026
Voltar para busca
Dado oficial do USPTO
KANGHONG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
22/05/2018
Data de registro
08/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/04/2026
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Sichuan, CN
Examinador
STINSON, JENNIFER ELLE
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of of a rounded chevron inside of a rectangle with rounded corners. To the right are two Chinese characters with a line underneath and the wording "KANGHONG" underneath the line.
Titulares e representantes
Titulares
Chengdu Kanghong Pharmaceuticals Group Co., Ltd.
Representantes
Jennifer Sheehan Anderson Bridge Intellectual Property Services
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Mothproofing preparations; Radioactive substances in the nature of drugs for medical purposes; Chemico-pharmaceutical preparations for reducing blood fat; Chemico-pharmaceutical preparations for promoting sleep; Chemico-pharmaceutical preparations for sedationanti-depressiontumor suppression; Chemico-pharmaceutical preparations for the treatment of diabetesdiseases of the central nervous systemdiseases of the respiratory systemcardiovascular diseases and cancer; Chemico-pharmaceutical preparations used in eye surgery and intraocular surgery; Pharmaceutical preparations in the nature of tissues impregnated with pharmaceutical skin lotions; Depuratives for the body; Media for bacteriological cultures; Medicinal preparations for the mouth to be applied in the form of tablets; Semen for artificial insemination; Medicines for human purposesmedicines for humans for the treatment or prevention of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalstomachdigestivehormonaldiabeticmuscularrheumaticimmune systemocular and metabolic diseases and disorders; Medicines for humans to treat or prevent diabetescoughscoldsinfluenzaheadaches and allergic reactions; Vermin destroying preparations; Biochemical drug for medical purposes for the treatment of cancer and ophthalmic diseases; Suppositories; Pharmaceutical preparations in the form of liquids for the treatment of central nervous system diseasestumorsdiabetesophthalmic diseases; Pharmaceutical preparations in the form of liquids for the treatment of cancer; Disinfectants for hygiene purposes; Mosquito-repellent incense; Sanitary sterilizing preparations in the nature of tissues impregnated with sterilization preparations; Chemical conductors for electrocardiograph electrodes; Dental lacquer; Medicinal drinks in the nature of herb liqueurs; Pharmaceutical preparations used for the relief of pain and to reduce fever; Pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseaseshemophiliametabolic diseasescancermultiple sclerosisurologic diseasessexual dysfunctionosteoporosisclimacteric diseases; Pharmaceutical preparationsanticoagulants and platelet aggregation inhibitors; anti-infective pharmaceutical preparations; Pharmaceutical preparationsophthalmics; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Infusions for medical purposes for treating dermatological diseases; Gases for medical purposes; Wadding for medical purposes; Drugs for medical purposespharmaceutical preparations for anti-depressiontumor suppressionrelieving coughreducing blood pressure; Drugs for medical purposespharmaceutical preparations for the treatment central nervous system diseasesasthmadiabetesrespiratory system diseasescancercardiovascular diseasesgastrointestinal diseaseshyperlipidaemia and hypercholesteremia; Drugs for medical purposespharmaceutical preparations used in eye surgery and intraocular surgery; Bath preparations for medical purposes; Diagnostic agents for medical purposes; Solutions for contact lenses; Crude drugsnamely pharmaceutical preparations for the treatment of central nervous system diseasesnamely hypertensionhyperlipidemiaschizophrenia and melancholiadigestive system diseasesnamely dyspepsiachronic gastritischronic lithogenous cholecystitischronic cholecystitis and gall-stoneophthalmology system diseasesnamely wet Age-related Macular Degeneration (AMD)other diseasesnamely feverirritabilityred eyesmouth soressore throatswollen gumsconstipationpharyngitistonsillitisgingivitisupper respiratory infection (URI)acute bronchitisdiabetes and nephropathy; Pharmaceutical preparations in the form of injections for the treatment of central nervous system diseasesdiabetesfundus oculi disease and cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceutical preparations in the form of injections used in eye surgery and intraocular surgery; Traditional Chinese medicines for Chinese medicinal usedried Chinese boxthorn fruitsChinese-datepseudo-ginsengChinese angelica and ginseng; Traditional Chinese medicines for Chinese medicinal usedried Chinese boxthorn fruitsChinese-datepseudo-ginsengChinese angelica and ginseng sold as a kit in a Chinese medicine bag
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/02/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/02/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/03/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/02/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
03/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/07/2019
PUBO
PUBLISHED FOR OPPOSITION
23/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2019
ALIE
ASSIGNED TO LIE
14/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2019
RFNT
REFUSAL PROCESSED BY IB
28/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/12/2018
RFRR
REFUSAL PROCESSED BY MPU
13/12/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/11/2018
CNRT
NON-FINAL ACTION WRITTEN
29/11/2018
MAFR
APPLICATION FILING RECEIPT MAILED
27/11/2018
DOCK
ASSIGNED TO EXAMINER
23/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KANGHONG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.